While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy ...

Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...

The European Commission (EC) has authorised the use of ViiV Healthcare’s Vocabria (cabotegravir long-acting injections) plus ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it growsLONDON, Feb. 03, 2025 (GLOBE ...

Climate displacement is not a distant or hypothetical threat; it is a rapidly escalating health emergency. The pharmaceutical ...